- Home
- TIL vs MX Comparison
TIL vs MX Comparison
Compare TIL & MX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- MX
- Stock Information
- Founded
- TIL 2018
- MX 2003
- Country
- TIL United States
- MX South Korea
- Employees
- TIL N/A
- MX N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- MX Semiconductors
- Sector
- TIL Health Care
- MX Technology
- Exchange
- TIL Nasdaq
- MX Nasdaq
- Market Cap
- TIL 177.1M
- MX 145.3M
- IPO Year
- TIL 2021
- MX N/A
- Fundamental
- Price
- TIL $27.84
- MX $2.93
- Analyst Decision
- TIL Buy
- MX Strong Buy
- Analyst Count
- TIL 6
- MX 2
- Target Price
- TIL $120.50
- MX $5.75
- AVG Volume (30 Days)
- TIL 159.0K
- MX 385.1K
- Earning Date
- TIL 08-13-2025
- MX 07-31-2025
- Dividend Yield
- TIL N/A
- MX N/A
- EPS Growth
- TIL N/A
- MX N/A
- EPS
- TIL N/A
- MX N/A
- Revenue
- TIL N/A
- MX $234,243,000.00
- Revenue This Year
- TIL N/A
- MX N/A
- Revenue Next Year
- TIL N/A
- MX $7.05
- P/E Ratio
- TIL N/A
- MX N/A
- Revenue Growth
- TIL N/A
- MX 16.02
- 52 Week Low
- TIL $9.90
- MX $2.51
- 52 Week High
- TIL $92.00
- MX $5.16
- Technical
- Relative Strength Index (RSI)
- TIL 52.43
- MX 33.87
- Support Level
- TIL $25.79
- MX $2.67
- Resistance Level
- TIL $29.67
- MX $3.12
- Average True Range (ATR)
- TIL 2.62
- MX 0.18
- MACD
- TIL 0.10
- MX -0.04
- Stochastic Oscillator
- TIL 70.92
- MX 16.15
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely, Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.